Qlucore AB (publ) provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for multi-omics companion. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Stock data | 2023 | Change |
---|---|---|
Price | $0.7878901287215497 | N/A |
Market Cap | $3.17M | N/A |
Shares Outstanding | 4.03M | 0.00% |
Employees | 22.00 | N/A |
Shareholder Equity | 94.73M | -14.32% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.20 | N/A |
P/S Ratio | 2.54 | N/A |
P/B Ratio | 0.03 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0166 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $1.25M | N/A |
Earnings | -$1.57M | N/A |
EPS | -3.96 | N/A |
Earnings Yield | -5.02 | N/A |
Gross Margin | 0.458 | N/A |
Operating Margin | -1.29 | N/A |
Net income margin | -1.26 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $10.77M | N/A |
Total Debt | $439.05K | N/A |
Cash on Hand | $6.87M | N/A |
Debt to Equity | 0.0152 | 50.59% |
Cash to Debt | $15.64 | -14.85% |
Current Ratio | $6.45 | -56.34% |